255 related articles for article (PubMed ID: 7678708)
1. Activation in stored platelet concentrates: correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release.
Rinder HM; Snyder EL; Bonan JL; Napychank PA; Malkus H; Smith BR
Transfusion; 1993 Jan; 33(1):25-9. PubMed ID: 7678708
[TBL] [Abstract][Full Text] [Related]
2. Activation of platelet concentrate during preparation and storage.
Rinder HM; Snyder EL
Blood Cells; 1992; 18(3):445-56; discussion 457-60. PubMed ID: 1283703
[TBL] [Abstract][Full Text] [Related]
3. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage.
Fijnheer R; Modderman PW; Veldman H; Ouwehand WH; Nieuwenhuis HK; Roos D; de Korte D
Transfusion; 1990 Jan; 30(1):20-5. PubMed ID: 1688666
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
5. ADP causes partial degranulation of platelets in the absence of aggregation.
Janes SL; Wilson DJ; Cox AD; Chronos NA; Goodall AH
Br J Haematol; 1994 Mar; 86(3):568-73. PubMed ID: 7519037
[TBL] [Abstract][Full Text] [Related]
6. Platelet alpha-granule secretion and its modification by SC-57101A, a GPIIb/IIIa antagonist.
Ogawa T; Sugidachi A; Otsuguro K; Isobe T; Asai F
Biochem Pharmacol; 2002 May; 63(10):1911-8. PubMed ID: 12034376
[TBL] [Abstract][Full Text] [Related]
7. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.
Inoue T; Sohma R; Morooka S
Thromb Res; 1999 Feb; 93(3):137-43. PubMed ID: 10030830
[TBL] [Abstract][Full Text] [Related]
8. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
[TBL] [Abstract][Full Text] [Related]
9. [Platelet membrane glycoproteins in thrombocytapheresis and platelet concentrates].
Dittmann J; Riggert J; Wieding JU; Simson G; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():422-7. PubMed ID: 9480137
[TBL] [Abstract][Full Text] [Related]
10. Soluble P-selectin as parameter for platelet activation during storage.
Kostelijk EH; Fijnheer R; Nieuwenhuis HK; Gouwerok CW; de Korte D
Thromb Haemost; 1996 Dec; 76(6):1086-9. PubMed ID: 8972035
[TBL] [Abstract][Full Text] [Related]
11. Platelet activation in acute pancreatitis.
Osada J; Wereszczynska-Siemiatkowska U; Dabrowski A; Dabrowska MI
Pancreas; 2012 Nov; 41(8):1319-24. PubMed ID: 22617709
[TBL] [Abstract][Full Text] [Related]
12. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
[TBL] [Abstract][Full Text] [Related]
13. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods.
Fijnheer R; Pietersz RN; de Korte D; Gouwerok CW; Dekker WJ; Reesink HW; Roos D
Transfusion; 1990 Sep; 30(7):634-8. PubMed ID: 2144922
[TBL] [Abstract][Full Text] [Related]
14. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
15. Storage of buffy-coat-derived platelets in additive solutions at 4 degrees C and 22 degrees C: flow cytometry analysis of platelet glycoprotein expression.
Sandgren P; Hansson M; Gulliksson H; Shanwell A
Vox Sang; 2007 Jul; 93(1):27-36. PubMed ID: 17547562
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
17. Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity.
Peerschke EI; Reid KB; Ghebrehiwet B
J Exp Med; 1993 Aug; 178(2):579-87. PubMed ID: 7688027
[TBL] [Abstract][Full Text] [Related]
18. Single-donor platelet concentrates: changes of surface glycoproteins during storage.
Böck M; Gawaz MP; Dietzler A; Heim MU; Mempel W
Haemostasis; 1994; 24(4):230-5. PubMed ID: 7527367
[TBL] [Abstract][Full Text] [Related]
19. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
[TBL] [Abstract][Full Text] [Related]
20. Thrombogenesis in sickle cell disease.
Tomer A; Harker LA; Kasey S; Eckman JR
J Lab Clin Med; 2001 Jun; 137(6):398-407. PubMed ID: 11385360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
